Application 202833
- Type
- NDA
- Sponsor
- LEO LABS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PICATO | INGENOL MEBUTATE | GEL;TOPICAL | 0.015% | Yes | Yes |
| 002 | PICATO | INGENOL MEBUTATE | GEL;TOPICAL | 0.05% | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N202833-001 | PICATO | INGENOL MEBUTATE | 0.015% | GEL / TOPICAL | RLD | 2012-01-23 | |
| N202833-002 | PICATO | INGENOL MEBUTATE | 0.05% | GEL / TOPICAL | RLD | 2012-01-23 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N202833-001 | 8372827 | 2026-12-18 | Drug product | 2013-03-08 | |
| N202833-001 | 8372828 | 2026-12-18 | Drug product | 2013-03-08 | |
| N202833-001 | 8377919 | 2026-12-18 | Drug product | 2013-03-08 | |
| N202833-001 | 8536163 | 2026-12-18 | U-1440 | 2013-10-15 | |
| N202833-001 | 8716271 | 2026-12-18 | U-1440 | 2014-05-28 | |
| N202833-001 | 8735375 | 2026-12-18 | U-1440 | 2014-06-26 | |
| N202833-001 | 9820959 | 2026-12-18 | U-1440 | Drug product | 2017-11-22 |
| N202833-001 | 9833428 | 2026-12-18 | Drug product | 2017-12-06 | |
| N202833-001 | 9833429 | 2026-12-18 | Drug product | 2017-12-06 | |
| N202833-001 | 9861603 | 2026-12-18 | U-1440 | 2018-01-16 | |
| N202833-001 | 8278292 | 2027-07-06 | Drug product | 2012-10-23 | |
| N202833-001 | 9789078 | 2033-05-15 | U-2138 | 2017-11-15 | |
| N202833-002 | 8372827 | 2026-12-18 | Drug product | ||
| N202833-002 | 8372828 | 2026-12-18 | Drug product | ||
| N202833-002 | 8377919 | 2026-12-18 | Drug product | ||
| N202833-002 | 8536163 | 2026-12-18 | U-1440 | 2013-10-15 | |
| N202833-002 | 8716271 | 2026-12-18 | U-1440 | 2014-05-28 | |
| N202833-002 | 8735375 | 2026-12-18 | U-1440 | 2014-06-26 | |
| N202833-002 | 9820959 | 2026-12-18 | U-1440 | Drug product | 2017-11-22 |
| N202833-002 | 9833428 | 2026-12-18 | Drug product | 2017-12-06 | |
| N202833-002 | 9833429 | 2026-12-18 | Drug product | 2017-12-06 | |
| N202833-002 | 9861603 | 2026-12-18 | U-1440 | 2018-01-16 | |
| N202833-002 | 8278292 | 2027-07-06 | Drug product |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N202833-001 | PICATO | 0.015% | GEL / TOPICAL | RLD | 2012-01-23 | 3a93d1ddd44b… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N202833-002 | PICATO | 0.05% | GEL / TOPICAL | RLD | 2012-01-23 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N202833-001 | PICATO | 0.015% | GEL / TOPICAL | RLD | 2012-01-23 | f41ea6bd6efb… | |
| 2022-10-28 04:53 UTC | 2022-10 | N202833-002 | PICATO | 0.05% | GEL / TOPICAL | RLD | 2012-01-23 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N202833-001 | PICATO | 0.015% | GEL / TOPICAL | RLD | 2012-01-23 | e64feba35796… | |
| 2022-09-29 23:25 UTC | 2022-09 | N202833-002 | PICATO | 0.05% | GEL / TOPICAL | RLD | 2012-01-23 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N202833-001 | PICATO | 0.015% | GEL / TOPICAL | RLD | 2012-01-23 | cb3db0bc1861… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N202833-002 | PICATO | 0.05% | GEL / TOPICAL | RLD | 2012-01-23 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N202833-001 | PICATO | 0.015% | GEL / TOPICAL | RLD | 2012-01-23 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N202833-002 | PICATO | 0.05% | GEL / TOPICAL | RLD | 2012-01-23 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N202833-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N202833-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | N202833-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N202833-002 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N202833-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N202833-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N202833-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N202833-002 | AB | 1 | ea99ee380514… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N202833-001 | 8372827 | 2026-12-18 | Drug product | 2013-03-08 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N202833-001 | 8372828 | 2026-12-18 | Drug product | 2013-03-08 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N202833-001 | 8377919 | 2026-12-18 | Drug product | 2013-03-08 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N202833-001 | 8536163 | 2026-12-18 | U-1440 | 2013-10-15 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N202833-001 | 8716271 | 2026-12-18 | U-1440 | 2014-05-28 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N202833-001 | 8735375 | 2026-12-18 | U-1440 | 2014-06-26 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N202833-001 | 9820959 | 2026-12-18 | U-1440 | Drug product | 2017-11-22 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N202833-001 | 9833428 | 2026-12-18 | Drug product | 2017-12-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N202833-001 | 9833429 | 2026-12-18 | Drug product | 2017-12-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N202833-001 | 9861603 | 2026-12-18 | U-1440 | 2018-01-16 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N202833-001 | 8278292 | 2027-07-06 | Drug product | 2012-10-23 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N202833-001 | 9789078 | 2033-05-15 | U-2138 | 2017-11-15 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N202833-002 | 8372827 | 2026-12-18 | Drug product | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N202833-002 | 8372828 | 2026-12-18 | Drug product | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N202833-002 | 8377919 | 2026-12-18 | Drug product | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N202833-002 | 8536163 | 2026-12-18 | U-1440 | 2013-10-15 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N202833-002 | 8716271 | 2026-12-18 | U-1440 | 2014-05-28 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N202833-002 | 8735375 | 2026-12-18 | U-1440 | 2014-06-26 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N202833-002 | 9820959 | 2026-12-18 | U-1440 | Drug product | 2017-11-22 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N202833-002 | 9833428 | 2026-12-18 | Drug product | 2017-12-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N202833-002 | 9833429 | 2026-12-18 | Drug product | 2017-12-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N202833-002 | 9861603 | 2026-12-18 | U-1440 | 2018-01-16 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N202833-002 | 8278292 | 2027-07-06 | Drug product | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | N202833-001 | 8372827 | 2026-12-18 | Drug product | 2013-03-08 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N202833-001 | 8372828 | 2026-12-18 | Drug product | 2013-03-08 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N202833-001 | 8377919 | 2026-12-18 | Drug product | 2013-03-08 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N202833-001 | 8536163 | 2026-12-18 | U-1440 | 2013-10-15 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N202833-001 | 8716271 | 2026-12-18 | U-1440 | 2014-05-28 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N202833-001 | 8735375 | 2026-12-18 | U-1440 | 2014-06-26 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N202833-001 | 9820959 | 2026-12-18 | U-1440 | Drug product | 2017-11-22 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N202833-001 | 9833428 | 2026-12-18 | Drug product | 2017-12-06 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N202833-001 | 9833429 | 2026-12-18 | Drug product | 2017-12-06 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N202833-001 | 9861603 | 2026-12-18 | U-1440 | 2018-01-16 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N202833-001 | 8278292 | 2027-07-06 | Drug product | 2012-10-23 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N202833-001 | 9789078 | 2033-05-15 | U-2138 | 2017-11-15 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N202833-002 | 8372827 | 2026-12-18 | Drug product | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N202833-002 | 8372828 | 2026-12-18 | Drug product | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N202833-002 | 8377919 | 2026-12-18 | Drug product | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N202833-002 | 8536163 | 2026-12-18 | U-1440 | 2013-10-15 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N202833-002 | 8716271 | 2026-12-18 | U-1440 | 2014-05-28 | c2088c7a36db… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50222-502 | Picato | ingenol mebutate | LEO Pharma Inc. | NDA | Current |
| 50222-502 | Picato | ingenol mebutate | LEO Pharma Inc. | NDA | Current |
| 50222-502 | Picato | ingenol mebutate | LEO Pharma Inc. | NDA | Current |
| 50222-502 | Picato | ingenol mebutate | LEO Pharma Inc. | NDA | Current |
| 50222-502 | Picato | ingenol mebutate | LEO Pharma Inc. | NDA | Current |
| 50222-502 | Picato | ingenol mebutate | LEO Pharma Inc. | NDA | Current |
| 50222-503 | Picato | ingenol mebutate | LEO Pharma Inc. | NDA | Current |
| 50222-503 | Picato | ingenol mebutate | LEO Pharma Inc. | NDA | Current |
| 50222-503 | Picato | ingenol mebutate | LEO Pharma Inc. | NDA | Current |
| 50222-503 | Picato | ingenol mebutate | LEO Pharma Inc. | NDA | Current |
| 50222-503 | Picato | ingenol mebutate | LEO Pharma Inc. | NDA | Current |
| 50222-503 | Picato | ingenol mebutate | LEO Pharma Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 66847 | SUPPL | 2021-03-24 |
| 66826 | SUPPL | 2021-03-22 |
| 65717 | SUPPL | 2020-12-23 |
| 65619 | SUPPL | 2020-12-17 |
| 61894 | SUPPL | 2020-02-14 |
| 61888 | SUPPL | 2020-02-14 |
| 57652 | SUPPL | 2019-02-15 |
| 45405 | SUPPL | 2016-09-15 |
| 45326 | SUPPL | 2016-09-15 |
| 40230 | SUPPL | 2015-11-25 |
| 10118 | SUPPL | 2015-11-20 |
| 19388 | SUPPL | 2015-10-08 |
| 10119 | SUPPL | 2015-10-07 |
| 40229 | SUPPL | 2014-03-26 |
| 32321 | SUPPL | 2014-03-14 |
| 43416 | ORIG | 2012-03-02 |
| 32320 | ORIG | 2012-01-30 |
| 19387 | ORIG | 2012-01-25 |